Brainstorm cell therapeutics to announce third quarter results and provide a corporate update

New york , nov. 7, 2022 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that it will hold a conference call to update shareholders on financial results for the third quarter ended september 30, 2022, and provide a corporate update, at 8:00 a.m. eastern time on monday, november 14, 2022.
BCLI Ratings Summary
BCLI Quant Ranking